Arrowhead Pharmaceuticals Inc. appointed William Waddill as an independent director, effective Jan. 1, 2018.
Most recently, Waddill was senior vice president and CFO of Calithera Biosciences Inc.
Discover more about S&P Global’s offerings
Arrowhead Pharmaceuticals appoints director
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Arrowhead Pharmaceuticals Inc. appointed William Waddill as an independent director, effective Jan. 1, 2018.
Most recently, Waddill was senior vice president and CFO of Calithera Biosciences Inc.